MSC Industrial Direct Co., Inc., together with its subsidiaries, distributes metalworking and maintenance, repair, and operations (MRO) products and services in the United States, Canada, Mexico, the United Kingdom, and internationally. The company's MRO products include cutting tools, measuring instruments, tooling components, metalworking products, fasteners, flat stock products, raw materials, abrasives, machinery hand and power tools, safety and janitorial supplies, plumbing supplies, materials handling products, power transmission components, and electrical supplies. It offers stock-keeping units through its catalogs and brochures; e-commerce channels, including its website, mscdirect.com; inventory management solutions; and customer care centers, customer fulfillment centers, regional inventory centers, and warehouses. The company serves individual machine shops, manufacturing companies, and government agencies. MSC Industrial Direct Co., Inc. was founded in 1941 and is headquartered in Melville, New York.

MSC Industrial Direct Company, Inc.

ScanSource, Inc. SCSC reported adjusted earnings of $1.02 per share in fourth-quarter fiscal 2025 (ended June 30, 2025), beating the Zacks Consensus Estimate of 91 cents. The bottom line improved 28% from the prior-year quarter’s earnings of 80 cents.
On a reported basis, the company delivered earnings of 88 cents per share compared with the prior-year quarter’s 64 cents per share.
ScanSource, Inc. Price, Consensus and EPS Surprise
SCSC’s Revenues Rise Y/Y On North America Growth
The company reported net revenues of $813 million in the quarter under review, up 8.9% from the year-ago quarter. The top line beat the Zacks Consensus Estimate of $773 million.
Net revenues in the United States and Canada were up 12.2% to $745 million. International sales decreased 17.4% to $68.2 million.
Specialty Technology Solutions’ revenues rose 9.2% to $789 million in fourth-quarter fiscal 2024, courtesy of broad-based growth in North America.
Revenues at Intelisys & Advisory were $24.2 million in the reported quarter, up 1.3% year over year, driven by acquisitions.
ScanSource’s Adjusted EBITDA Margin Rises in Q4
The cost of sales amounted to $708 million in the fiscal fourth quarter, up 9.1% from the year-ago quarter. The gross profit totaled $105 million, up 8% from the year-ago quarter’s $97 million. The gross margin came in at 12.9% in the reported quarter compared with the prior-year quarter’s 13%.
Selling, general and administrative expenses increased 4.7% year over year to $72 million. The adjusted operating profit was $31 million in comparison to the prior-year quarter’s $26 million. Adjusted EBITDA was up 13% year over year to $38.6 million. The adjusted EBITDA margin was 4.7% compared with 4.6% in the prior-year quarter.
SCSC’s Cash Position & Balance Sheet
The company reported cash and cash equivalents of $126 million as of June 30, 2025, in comparison to $185 million as of June 30, 2024. The company generated $112 million of cash in operating activities in fiscal 2025 compared with $372 million in the prior year. The company’s long-term debt was $128 million at the end of fiscal 2025, down from $136 million at the end of fiscal 2024.
FY24 Performance of ScanSource
SCSC reported adjusted earnings per share of $3.57 in fiscal 2025 in comparison with $3.08 in the prior year. The bottom line beat the Zacks Consensus Estimate of $3.47.
Including one-time items, the bottom line came in at $3.00, declining 2% from $3.06 in fiscal 2024. Revenues were down 6.7% year over year to $3.04 billion. The top line beat the Zacks Consensus Estimate of $3.01 billion.
SCSC FY26 Outlook
ScanSource expects net revenues of $3.1-$3.3 billion for fiscal 2026. Adjusted EBITDA is projected between $150 million and $160 million. The company expects a free cash flow of at least $80 million.
ScanSource’s Share Price Performance
The company's shares have lost 8.7% in the past year against the industry’s 18% growth.
Image Source: Zacks Investment Research
SCSC’s Zacks Rank
ScanSource currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
SCSC’s Peer Performances
MSC Industrial Direct Company, Inc. MSM reported a third-quarter fiscal 2025 (ended on May 31, 2025) adjusted EPS of $1.08, which beat the Zacks Consensus Estimate of $1.03. The bottom line decreased 18.8% year over year.
MSC Industrial generated revenues of around $971 million in the quarter under review, down 0.8% from $979 million in the year-ago quarter. The top line beat the Zacks Consensus Estimate of $970 million. Average daily sales fell 0.8% year over year in the quarter. However, this came in line with the company’s expectations, driven by improving performance in volumes.
SiteOne Landscape Supply, Inc. SITE posted an adjusted EPS of $2.86 in the second quarter of 2025, missing the Zacks Consensus Estimate of $2.89. The company posted earnings of $2.63 per share in the second quarter of 2024.
SITE registered revenues of $1.46 billion for the June-end quarter of 2025, in line with the Zacks Consensus Estimate. The top line rose 3.4% year over year.
W.W. Grainger, Inc. GWW reported earnings per share (EPS) of $9.97 in second-quarter 2025, missing the Zacks Consensus Estimate of $10.00. However, the bottom line improved 2% year over year.
Grainger’s quarterly revenues rose 5.6% year over year to $4.55 billion. The top line beat the Zacks Consensus Estimate of $4.52 billion. Daily sales increased 5.6% from the prior-year quarter. We predicted daily sales to increase 3.8% in the quarter.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

ScanSource Q4 Earnings Surpass Estimates, Revenues Increase Y/Y

W.W. Grainger, Inc. GWW has reported earnings per share (EPS) of $9.97 in second-quarter 2025, missing the Zacks Consensus Estimate of $10.00. However, the bottom line improved 2% year over year.
Grainger’s quarterly revenues rose 5.6% year over year to $4.55 billion. The top line beat the Zacks Consensus Estimate of $4.52 billion. Daily sales increased 5.6% from the prior-year quarter. We predicted daily sales to increase 3.8% in the quarter.
W.W. Grainger, Inc. Price, Consensus and EPS Surprise
Grainger’s Q2 Segmental Performance
The High-Touch Solutions N.A. segment’s daily sales moved up 2.5% in the quarter from the second quarter of 2025, backed by growth across all geographies. Our model predicted year-over-year daily sales growth of 2.2% for the quarter.
The Endless Assortment segment’s daily sales grew 19.7% in the quarter due to solid performance at both MonotaRO and Zoro. The reported figure beat our estimated growth of 11%.
GWW’s Q2 Margins Dip Y/Y
Cost of sales rose 6.9% year over year to $2.8 billion. The gross profit rose 3.6% year over year to $1.75 billion. The gross margin came in at 38.5% compared with 39.3% in the prior-year quarter.
The company’s operating income in the quarter was up 4.5% year over year to $678 million. The operating margin was 14.9% compared with 15.1% in the prior-year quarter.
Grainger’s Q2 Cash Flow & Balance Sheet Updates
GWW had cash and cash equivalents of $0.6 billion at the end of the second quarter of 2025, down from $1 billion at the 2024 end. The cash flow from operating activities was $377 million in the second quarter of 2025 compared with $411 million in the prior-year quarter.
Long-term debt was $2.34 billion as of June 30, 2025, compared with $2.28 billion as of Dec. 31, 2025. Grainger returned $336 million to shareholders through dividends and share buybacks in the reported quarter.
GWW Updates 2025 Outlook
GWW expects net sales between $17.9 billion and $18.2 billion, updated from the prior stated $17.6-$18.1 million. Sales growth is anticipated to be 4.4-5.9%. Daily sales growth is envisioned at 4.5-6% compared with the earlier mentioned 4-6.5%. EPS is expected to be $38.50-$40.25 compared with the prior stated $39.00-$41.50.
Grainger Stock’s Price Performance
In the past year, the company’s shares have gained 11.2% compared with the industry’s growth of 16.6%.
Image Source: Zacks Investment Research
GWW’s Zacks Rank
Grainger currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Peer Performance
MSC Industrial Direct Company, Inc. MSM reported a third-quarter fiscal 2025 (ended on May 31, 2025) adjusted EPS of $1.08, which beat the Zacks Consensus Estimate of $1.03. The bottom line decreased 18.8% year over year.
MSC Industrial generated revenues of around $971 million in the quarter under review, down 0.8% from $979 million in the year-ago quarter. The top line beat the Zacks Consensus Estimate of $970 million. Average daily sales fell 0.8% year over year in the quarter. However, this came in line with the company’s expectations, driven by improving performance in volumes.
SiteOne Landscape Supply, Inc. SITE reported an adjusted EPS of $2.86 in the second quarter of 2025, missing the Zacks Consensus Estimate of $2.89. The company posted earnings of $2.63 per share in the second quarter of 2024.
SITE registered revenues of $1.46 billion for the June-end quarter of 2025, in line with the Zacks Consensus Estimate. The top line rose 3.4% year over year.
Industrial Services Stock Awaiting Results
Hillenbrand, Inc. HI is set to release third-quarter fiscal 2025 results on Aug. 11.
The Zacks Consensus Estimate for HI’s EPS is pegged at 50 cents for the fiscal third quarter, suggesting a decline of 41.2% from the year-ago reported figure. The Zacks Consensus Estimate for total revenues is pinned at $572.4 million, indicating a year-over-year decrease of 27.3%.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Grainger Earnings Miss Estimates in Q2, Revenues Increase Y/Y

Fastenal Company’s FAST second-quarter 2025 adjusted earnings and revenues came ahead of the Zacks Consensus Estimate and increased year over year.
Second-quarter results reflect operational discipline, customer expansion and resilience despite broader macro sluggishness. FAST stock gained 3.3% after the earnings results on Friday.
Fastenal’s Earnings & Sales in Detail
The company reported earnings per share (EPS) of 29 cents, which beat the Zacks Consensus Estimate of 28 cents and grew 12.7% from the year-ago level of 25 cents per share.
Net sales rose 8.6% year over year to $2.08 billion, topping the consensus mark of $2.06 billion. Daily sales also climbed 8.6%, driven primarily by improved customer contract momentum and increased unit sales. Growth came despite a sluggish industrial environment, as larger contract customers and key manufacturing accounts continued to drive incremental gains. Foreign exchange rates positively impacted sales by 10 basis points (bps).
Fastenal's unit sales rose in the quarter, driven by more customer sites spending more than $10K per month and modest growth in average sales per site. Product pricing also contributed positively, adding 140–170 bps to net sales.
Fastenal Company Price, Consensus and EPS Surprise
Daily sales of Fasteners (mainly used for industrial production and accounting for approximately 30.5% of net sales) increased 6.6% year over year. Sales of Safety Supplies (22.2%) grew 10.7% daily. Sales of the Other Product Lines (47.3%) also increased 9% year over year.
On an end-market basis, the daily sales rate of Heavy Manufacturing (which accounted for approximately 42.9% of net sales) rose 7.5% year over year. The daily sales rate of Other Manufacturing (33%) grew 11% compared with the prior year.
Furthermore, the daily sales of Non-Residential Construction grew 3% compared with the prior-year quarter, while the same for Other End-Markets grew 8.7% in the same time frame.
Daily sales through weighted FMI devices grew 14.4% for the second quarter, representing 44.1% of net sales. In the quarter, daily sales through eProcurement rose 19.3%, while daily sales via eCommerce declined 4.2%.
In the second quarter of 2025, Digital Footprint sales (which include FMI technology and non-FMI eBusiness) accounted for 61% of total sales, up from 59.4% in the year-ago period. The company's revised 2025 target for Digital Footprint penetration is 63%–64%, down from the prior goal of 66%–68%.
Margin Discussion of Fastenal
The gross margin was 45.3% in the reported quarter, up 20 bps year over year. Our model predicted a gross margin of 44.9% for the quarter. This upside was due to increased fastener product availability, which resulted in higher sales and improved gross margin.
Selling, general and administrative expenses – as a percentage of net sales – improved to 24.4% from 24.9% reported in the year-ago quarter. Our model predicted SG&A expenses to improve to 24.3%.
Operating margin was 21% (higher than our projection of 20.6%), up from 20.2% a year ago.
FAST’s Financials
As of June 30, 2025, Fastenal had cash and cash equivalents of $237.8 million, down from $255.8 million as of Dec. 31, 2024. The long-term debt at the end of the second quarter of 2025 was $100 million, down from $125 million at 2024-end. During the quarter, FAST returned $252.5 million to its shareholders in the form of dividends.
In the second quarter of 2025, net cash provided by operating activities totaled $278.6 million, up 8.1% from the year-ago period.
FAST’s Zacks Rank & Key Picks
Fastenal currently carries a Zacks Rank #3 (Hold).
Here are some better-ranked stocks from the Zacks Industrial Products sector.
MSC Industrial Direct Co., Inc. MSM currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The MSC stock has gained 21% year to date (YTD). The company has a trailing four-quarter earnings surprise of 6%, on average. The Zacks Consensus Estimate for MSC’s fiscal 2025 sales and EPS indicates a decline of 1.9% and 24.1%, respectively, from the year-ago period’s levels.
IperionX Limited IPX currently carries a Zacks Rank #2 (Buy). IperionX stock has lost 4.4% YTD.
The Zacks Consensus Estimate for IperionX’s current year’s bottom line is expected to improve to a loss of 2 cents per share compared with a 10-cent loss reported in the year-ago period.
Siemens Aktiengesellschaft SIEGY currently carries a Zacks Rank #2. Siemens stock has gained 34.9% YTD.
The Zacks Consensus Estimate for Siemens’ current year’s sales and EPS indicates growth of 2.3% and 20.5%, respectively, from the year-ago period’s levels.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include
Stock #1: A Disruptive Force with Notable Growth and Resilience
Stock #2: Bullish Signs Signaling to Buy the Dip
Stock #3: One of the Most Compelling Investments in the Market
Stock #4: Leader In a Red-Hot Industry Poised for Growth
Stock #5: Modern Omni-Channel Platform Coiled to Spring
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.
Download Atomic Opportunity: Nuclear Energy's Comeback free today.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Fastenal Q2 Earnings & Sales Beat Estimates, Stock Rises

MSC Industrial (MSM) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.33 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +4.85%. A quarter ago, it was expected that this distributor of industrial tools and supplies would post earnings of $0.68 per share when it actually produced earnings of $0.72, delivering a surprise of +5.88%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
MSC Industrial, which belongs to the Zacks Industrial Services industry, posted revenues of $971.15 million for the quarter ended May 2025, surpassing the Zacks Consensus Estimate by 0.10%. This compares to year-ago revenues of $979.35 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
MSC Industrial shares have added about 13.8% since the beginning of the year versus the S&P 500's gain of 5.5%.
What's Next for MSC Industrial?
While MSC Industrial has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for MSC Industrial was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.93 on $946.5 million in revenues for the coming quarter and $3.55 on $3.74 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Industrial Services is currently in the top 31% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, SiteOne Landscape (SITE), has yet to report results for the quarter ended June 2025.
This company is expected to post quarterly earnings of $2.89 per share in its upcoming report, which represents a year-over-year change of +9.9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
SiteOne Landscape's revenues are expected to be $1.48 billion, up 4.9% from the year-ago quarter.
Should You Invest in MSC Industrial Direct Company, Inc. (MSM)?
Before you invest in MSC Industrial Direct Company, Inc. (MSM), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.
Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

MSC Industrial (MSM) Q3 Earnings and Revenues Beat Estimates

(RTTNews) - MSC Industrial Direct Company Inc. (MSM) reported a profit for third quarter that decreased from the same period last year but beat the Street estimates.
The company's earnings came in at $56.8 million, or $1.02 per share. This compares with $71.7 million, or $1.27 per share, last year.
Excluding items, MSC Industrial Direct Company Inc. reported adjusted earnings of $60.2 million or $1.08 per share for the period.
Analysts on average had expected the company to earn $1.03 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 0.8% to $971.1 million from $979.4 million last year.
MSC Industrial Direct Company Inc. earnings at a glance (GAAP) :
-Earnings: $56.8 Mln. vs. $71.7 Mln. last year. -EPS: $1.02 vs. $1.27 last year. -Revenue: $971.1 Mln vs. $979.4 Mln last year.
Looking ahead, for the full year, MSM has reaffirmed its outlook for capital expenditure of around $100 million to $110 million.
The company still expects annual depreciation and amortization expense of approximately $90 million to $95 million.
MSM was up by 3.58% at $88 in the pre-market trade on the New York Stock Exchange.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

MSC Industrial Direct Company Inc. Q3 Profit Decreases, But Beats Estimates

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Sonoco Products Co. (Symbol: SON), where a total volume of 6,013 contracts has been traded thus far today, a contract volume which is representative of approximately 601,300 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 82.5% of SON's average daily trading volume over the past month, of 728,855 shares. Particularly high volume was seen for the $35 strike call option expiring July 18, 2025, with 6,000 contracts trading so far today, representing approximately 600,000 underlying shares of SON. Below is a chart showing SON's trailing twelve month trading history, with the $35 strike highlighted in orange:
MSC Industrial Direct Co Inc (Symbol: MSM) options are showing a volume of 3,668 contracts thus far today. That number of contracts represents approximately 366,800 underlying shares, working out to a sizeable 78.9% of MSM's average daily trading volume over the past month, of 464,850 shares. Particularly high volume was seen for the $95 strike call option expiring July 18, 2025, with 755 contracts trading so far today, representing approximately 75,500 underlying shares of MSM. Below is a chart showing MSM's trailing twelve month trading history, with the $95 strike highlighted in orange:
And Starbucks Corp. (Symbol: SBUX) options are showing a volume of 68,713 contracts thus far today. That number of contracts represents approximately 6.9 million underlying shares, working out to a sizeable 77.8% of SBUX's average daily trading volume over the past month, of 8.8 million shares. Especially high volume was seen for the $97 strike call option expiring July 03, 2025, with 13,535 contracts trading so far today, representing approximately 1.4 million underlying shares of SBUX. Below is a chart showing SBUX's trailing twelve month trading history, with the $97 strike highlighted in orange:
For the various different available expirations for SON options, MSM options, or SBUX options, visit StockOptionsChannel.com.
MDWD YTD Return
Institutional Holders of XXV
Funds Holding XP
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Notable Monday Option Activity: SON, MSM, SBUX

MSC INDUSTRIAL DIRECT ($MSM) is expected to release its quarterly earnings data on Tuesday, July 1st before market open, per Finnhub. Analysts are expecting revenue of $979,957,297 and earnings of $1.04 per share.
You can see Quiver Quantitative's $MSM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MSC INDUSTRIAL DIRECT Insider Trading Activity
MSC INDUSTRIAL DIRECT insiders have traded $MSM stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MSM stock by insiders over the last 6 months:
MITCHELL JACOBSON has made 4 purchases buying 159,193 shares for an estimated $11,101,252 and 0 sales.
MSC INDUSTRIAL DIRECT Hedge Fund Activity
We have seen 200 institutional investors add shares of MSC INDUSTRIAL DIRECT stock to their portfolio, and 241 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
PACER ADVISORS, INC. removed 882,409 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $68,536,707
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 794,007 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $59,304,382
VICTORY CAPITAL MANAGEMENT INC added 636,827 shares (+445.4%) to their portfolio in Q1 2025, for an estimated $49,462,353
SG CAPITAL MANAGEMENT LLC added 633,586 shares (+inf%) to their portfolio in Q1 2025, for an estimated $49,210,624
MACKENZIE FINANCIAL CORP added 497,810 shares (+6108.1%) to their portfolio in Q1 2025, for an estimated $38,664,902
NORGES BANK added 400,990 shares (+625.8%) to their portfolio in Q4 2024, for an estimated $29,949,943
AUTO-OWNERS INSURANCE CO removed 329,813 shares (-92.1%) from their portfolio in Q1 2025, for an estimated $25,616,575
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

MSC INDUSTRIAL DIRECT Earnings Preview: Recent $MSM Insider Trading, Hedge Fund Activity, and More

Ashtead Group plc ASHTY reported adjusted earnings of 79 cents per share in fourth-quarter fiscal 2025 (ended April 30, 2025), 1% lower than the year-ago quarter. ASHTY’s earnings per American Depositary Receipt (ADR) were $3.15. The metric beat the Zacks Consensus Estimate of $3.13 per share. Each Ashtead Group ADR represents four ordinary shares.
Ashtead Group Witnesses Higher Rental Revenues in Q4
The company reported net revenues of $2.53 billion, down 4% from the year-ago quarter. The top line missed the Zacks Consensus Estimate of $2.54 billion.
Rental revenues increased 1% year over year to $2.33 billion. The sale of new equipment, merchandise and consumables declined 8.6% to $83 million. The sale of used rental equipment plunged 49.9% to $112 million.
ASHTY’s Q4 Operating Profit Declines
Total operating costs slipped 6.4% year over year to $1.39 billion. The adjusted operating profit dipped 7% year over year to $523 million. The adjusted operating margin contracted 67 basis points to 20.7%.
Adjusted EBITDA rose 1% year over year to $1.15 billion due to higher depreciation and amortization. The EBITDA margin was 45.4% compared with the year-ago quarter’s 43.4%.
Ashtead Group’s Q4 Cash Position & Balance Sheet
The company reported cash and cash equivalents of $21 million as of April 30, 2025, compared with $20.8 million as of April 30, 2024. It generated $2.17 billion in cash from operating activities in fiscal 2025 compared with $0.85 billion in the prior-year period. The free cash flow in fiscal 2025 was $1.78 billion compared with $0.22 billion in the prior-year period.
ASHTY’s net debt was $10.33 billion at the end of the quarter, down from $10.65 billion at the end of the prior-year quarter. Ashtead Group’s net debt to adjusted EBITDA ratio was 2.1X as of April 30, 2025, compared with 2.2X as of April 30, 2024.
ASHTY FY25 Results
The company reported adjusted earnings of $3.69 per share in fiscal 2025, 4% lower than the year-ago quarter. ASHTY’s earnings per ADR were $14.78. The metric missed the Zacks Consensus Estimate of $15.53 per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
The company reported net revenues of $10.79 billion, down 1% from the year-ago quarter. The top line missed the Zacks Consensus Estimate of $12.38 billion. Record rental revenues were offset by the impacts of lower sales of used equipment.
Ashtead Group’s FY26 Guidance
The company expects total rental revenues to be flat to rise 4% in fiscal 2026. It expects the free cash flow to be $2-$2.3 billion.
ASHTY Stock’s Price Performance
The company’s shares have lost 10.3% in the past year compared with the industry’s 1.3% decline.
Image Source: Zacks Investment Research
Ashtead Group’s Zacks Rank
Ashtead Group currently has a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
ASHTY’s Peer Performances
W.W. Grainger, Inc. GWW reported earnings per share of $9.86 in first-quarter 2025, beating the Zacks Consensus Estimate of $9.46. The bottom line improved 2% year over year.
Grainger’s quarterly revenues rose 1.7% year over year to $4.31 billion. The top line missed the Zacks Consensus Estimate of $4.33 billion. Daily sales increased 3.3% from the prior-year quarter. We predicted daily sales to increase 2.7%.
MSC Industrial Direct Company, Inc. MSM reported second-quarter fiscal 2025 (ended on March 1, 2025) adjusted earnings per share of 72 cents, beating the Zacks Consensus Estimate of 68 cents. The bottom line decreased 39% year over year.
MSC Industrial generated revenues of around $892 million in the quarter under review, down 4.7% from $935 million in the year-ago quarter. MSM’s top line missed the Zacks Consensus Estimate of $899 million. Average daily sales fell 4.7% year over year in the quarter.
Hillenbrand, Inc. HI posted second-quarter fiscal 2025 adjusted earnings per share of 60 cents, beating the Zacks Consensus Estimate of 54 cents. The bottom line decreased 21% year over year.
HI generated revenues of around $716 million in the quarter under review, down 8.8% from $785 million in the year-ago quarter. Hillenbrand’s top line beat the Zacks Consensus Estimate of $691 million.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
W.W. Grainger, Inc. (GWW) : Free Stock Analysis Report
MSC Industrial Direct Company, Inc. (MSM) : Free Stock Analysis Report
Hillenbrand Inc (HI) : Free Stock Analysis Report
Ashtead Group PLC (ASHTY) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Ashtead Group Q4 Earnings Beat Estimates, Revenues Decrease 4% Y/Y

Sage Therapeutics, Inc. (SAGE) shares ended the last trading session 35.4% higher at $9.07. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.8% loss over the past four weeks.
The stock rallied after the company announced that Supernus Pharmaceuticals has agreed to acquire Sage Therapeutics through a tender offer of $8.50 per share in cash, totaling around $561 million. Additionally, shareholders will receive a non-tradable contingent value right (CVR) worth up to $3.50 per share, bringing the total potential value of the deal to $12 per share in cash, or approximately $795 million.
The transaction is expected to be closed in the third quarter of 2025, subject to customary closing conditions.
This company is expected to post quarterly loss of $0.96 per share in its upcoming report, which represents a year-over-year change of +43.5%. Revenues are expected to be $17.34 million, up 100.5% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Sage Therapeutics, the consensus EPS estimate for the quarter has been revised marginally lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on SAGE going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Sage Therapeutics is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, Compugen (CGEN), finished the last trading session 0.6% higher at $1.65. CGEN has returned 18% over the past month.
Compugen's consensus EPS estimate for the upcoming report has changed +82.9% over the past month to -$0.07. Compared to the company's year-ago EPS, this represents a change of -250%. Compugen currently boasts a Zacks Rank of #3 (Hold).
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sage Therapeutics, Inc. (SAGE) : Free Stock Analysis Report
Dr. Reddy's Laboratories Ltd (RDY) : Free Stock Analysis Report
Visa Inc. (V) : Free Stock Analysis Report
ArcelorMittal (MT) : Free Stock Analysis Report
MSC Industrial Direct Company, Inc. (MSM) : Free Stock Analysis Report
Compugen Ltd. (CGEN) : Free Stock Analysis Report
fuboTV Inc. (FUBO) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?

Personalis (PSNL) shares rallied 7.3% in the last trading session to close at $6.45. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 21.4% gain over the past four weeks.
The sudden uptrend in the stock price can be attributed to the positive investor mindset regarding the continued growth in revenues from the sale of Personalis’ pharma tests and services, signifying increasing adoption of its technology.
This provider of contract research and genomic information is expected to post quarterly loss of $0.25 per share in its upcoming report, which represents a year-over-year change of -4.2%. Revenues are expected to be $20.2 million, down 10.5% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Personalis, the consensus EPS estimate for the quarter has been revised 2% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on PSNL going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Personalis is part of the Zacks Medical - Generic Drugs industry. Doctor Reddy's (RDY), another stock in the same industry, closed the last trading session 0.5% lower at $15.72. RDY has returned 9.4% in the past month.
Doctor Reddy's' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.19. Compared to the company's year-ago EPS, this represents a change of -5%. Doctor Reddy's currently boasts a Zacks Rank of #3 (Hold).
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Personalis, Inc. (PSNL) : Free Stock Analysis Report
Dr. Reddy's Laboratories Ltd (RDY) : Free Stock Analysis Report
Visa Inc. (V) : Free Stock Analysis Report
ArcelorMittal (MT) : Free Stock Analysis Report
MSC Industrial Direct Company, Inc. (MSM) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.